Novo Nordisk A/S

Medicare coverage opens 15 million-patient opportunity

Read more

FDA says Novo Nordisk’s obesity pill TV ad includes misleading claims

Read more

Novo Nordisk sues Hims & Hers over compounded obesity drugs

Read more

Hims & Hers pulls copycat weight-loss pill after legal threats

Read more

White House launches direct to consumer drug site

Read more

Eli Lilly CEO David Ricks talks Medicare coverage of obesity pills

Read more

Next steps for Eli Lilly, Novo Nordisk, Pfizer

Read more

Novo Nordisk, Pfizer execs weigh in

Read more

Novo Nordisk shares rise after Wegovy obesity pill launch

Read more

2026 is the year of obesity pills from Novo Nordisk, Eli Lilly

Read more